GL1X · GenesisL1 explorer

MolNFT v1 · #175839 · protein

Crystal structure of BACE1 in complex with N-{3-[(3S)-1-amino-5- fluoro-3-methyl-3,4-dihydro-2,6-naphthyridin-3-yl]-4-fluorophenyl}-5- cyano-3-methylpyridine-2-carboxamide

7D36 · Beta-secretase 1: “Crystal structure of BACE1 in complex with N-{3-[(3S)-1-amino-5…”. X-ray diffraction, 2 ligands (GUC, IOD), 2 pockets (best druggability 0.62). MolNFT v1 #175839 on GenesisL1: 3D structure, binding sites and…

PDB
7D36
Type
protein
Length
378 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-secretase 1
EC
3.4.23.46
UniProt
P56817
Ligands
GUC, IOD
Pockets
2 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 16% helix, 41% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-secretase 1 (EC 3.4.23.46)protein37816% helix, 41% strandP56817

Ligands and binding sites

  • GUC · N-[3-[(3S)-1-azanyl-5-fluoranyl-3-methyl-4H-2,6-naphthyridin-3-yl]-4-fluoranyl-phenyl]-5-cyano-3-methyl-pyridine-2-carboxamide · ligand · chains A
  • IOD · Iodide ion · ion · 4 copies · chains A
  • GOL · Glycerol · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13830.620.7744GUC
2660.360.7716empty

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 7D36 · Crystal Structure of BACE1 in complex with N-{3-[(3S)-1-amino-5-fluoro-3-methyl-3,4-dihydr… · the same entry in another collection · chain A against A, TM-score 1.00
  • P56817 · AlphaFold monomer V2.0 prediction for beta-secretase 1 (P56817) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.